KERALA AYURVEDA
|
|
BOM : 530163     NSE :      | |
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive] Debt : High |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward Pledged Shares : NA |
Nov 07,2024 |
Price(EOD): ₹ 279.35
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 335.22 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
KERALA AYURVEDA | 0% | -3.7% | 26.8% |
SUN PHARMACEUTICAL INDUSTRIES | -3.6% | -7.2% | 59% |
CIPLA | 0.9% | -6.4% | 32.4% |
DR REDDYS LABORATORIES | 2.3% | -3.5% | 22% |
ZYDUS LIFESCIENCES | -3.1% | -8.7% | 70.3% |
DIVIS LABORATORIES | 1% | -0.5% | 69.4% |
MANKIND PHARMA | 1.3% | 1.5% | 56% |
TORRENT PHARMACEUTICALS | -1.5% | -11.2% | 63.4% |
LUPIN | -4% | -7.6% | 80.4% |
FUNDAMENTAL ANALYSIS OF KERALA AYURVEDA
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF KERALA AYURVEDA
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
-1474.25
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs -0.23 Cr
[Latest Qtr - Jun2024 - Consolidated Results ] 10.45
P/B Calculated based on Book Value of Rs 32.16 Cr
[Latest Year - Mar2024 - Consolidated Results ] 3.13
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 107.34 Cr
[Latest Qtr - Jun2024 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
NA 67% 190% |
SHARE PRICE MOMENTUM OF KERALA AYURVEDA
KERALA AYURVEDA vs SENSEX
DEBT OF KERALA AYURVEDA
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2024 2023 2022 Avg_3yrs |
1.57 5.45 7.43 4.82 |
2.4 27.42 22.6 17.47 |
[Last Annual Data : Mar2024]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF KERALA AYURVEDA
Pledged Promoter Shares |
NA | |
---|---|---|
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF KERALA AYURVEDA
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
0.31% -73.78% -73.77% 350% |
15.53% -47.62% 243.45% 251.99% |
QtrlyTrend |
2 | |
Latest Qtr: Jun2024 | ||
Quarterly Result Analysis → |
KERALA AYURVEDA related INDICES
You may also like the below Video Courses
FAQ about KERALA AYURVEDA
Is KERALA AYURVEDA good for long term investment?
As on Nov 07,2024, the Fundamentals of KERALA AYURVEDA look Poor and hence it may not be good for long term investment ! See Financial Performance of KERALA AYURVEDA . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is KERALA AYURVEDA UnderValued or OverValued?
As on Nov 07,2024, KERALA AYURVEDA is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of KERALA AYURVEDA ?
As on Nov 07,2024, the Intrinsic Value of KERALA AYURVEDA is Rs. 131.54 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. -14.70
Fair Value [Median EV / Sales Model] : Rs. 166.84
Fair Value [Median Price / Sales Model] : Rs. 96.24
Estimated Median Fair Value of KERALA AYURVEDA : Rs. 131.54
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.